What did the safety review actually assess?
WHO’s Global Advisory Committee on Vaccine Safety examined infertility and primary ovarian insufficiency at its December 2019 meeting, with findings published in January 2020. It considered case reports, safety-surveillance reports and epidemiological studies. The available evidence did not support an association with HPV vaccination. The date matters: this is an established review, not a new clinical study conducted in 2026.
A symptom appearing after a vaccination is a reason to assess and, where appropriate, report it. The timing alone cannot show that vaccination caused it. Researchers look across different types of evidence to assess whether the pattern supports a causal explanation. Equally, reassuring population evidence does not make a person’s symptoms unimportant.
Are ovarian insufficiency and infertility the same thing?
Primary ovarian insufficiency refers to loss of normal ovarian function before age 40. It can affect fertility, but the condition is not interchangeable with every difficulty conceiving. Keeping the terms separate helps explain what an individual study has, and has not, measured.
A prospective North American study followed people planning a pregnancy and assessed the chance of conception in each menstrual cycle. It found little overall association with HPV vaccination. It was observational, relied on reported vaccination history and included relatively few vaccinated male partners. It adds relevant evidence, but does not prove that every possible fertility outcome has been ruled out.
Why is vaccination deferred during pregnancy?
Advice about pregnancy concerns the timing of vaccination, rather than evidence that HPV vaccination causes infertility. HPV vaccine is not recommended during pregnancy. If you learn that you are pregnant after starting a course, tell your healthcare professional; remaining doses are deferred until after pregnancy.
An inadvertently administered dose is not, by itself, a reason to assume that harm has occurred. CDC’s guidance notes that inadvertent vaccination has not been linked to adverse pregnancy outcomes, while clinical-trial data in pregnant women are limited. Ask your treating professional to review the dates and advise on your individual circumstances.
What should I discuss if I am concerned?
Bring your vaccination dates, any relevant test results and a clear account of your symptoms or concerns. Ask whether a separate fertility or menstrual-health assessment is appropriate, and when any remaining vaccine doses should be reviewed. Do not use a vaccine-safety article to diagnose the cause of a fertility problem.
HPV vaccination prevents new infection with targeted HPV types; it is not a fertility treatment and does not clear an existing HPV infection. It also does not replace recommended cervical screening or follow-up. The useful decision is how vaccination fits your prevention and care plan, not whether it can improve your chance of becoming pregnant.